HomeCADL • NASDAQ
add
Candel Therapeutics Inc
Previous close
$5.26
Day range
$5.19 - $5.43
Year range
$4.25 - $14.60
Market cap
292.61M USD
Avg Volume
709.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.90M | 40.60% |
Net income | -11.27M | -5.85% |
Net profit margin | — | — |
Earnings per share | -0.23 | — |
EBITDA | -13.01M | -52.87% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 86.96M | 425.20% |
Total assets | 93.60M | 335.00% |
Total liabilities | 13.47M | -63.36% |
Total equity | 80.12M | — |
Shares outstanding | 54.90M | — |
Price to book | 3.60 | — |
Return on assets | -33.09% | — |
Return on capital | -35.53% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -11.27M | -5.85% |
Cash from operations | -10.24M | -55.73% |
Cash from investing | -117.00K | — |
Cash from financing | -3.37M | -301.01% |
Net change in cash | -13.72M | -180.31% |
Free cash flow | -8.52M | -156.97% |
About
Founded
2003
Headquarters
Website
Employees
38
